Correlation of the ALA-PDT Treatment Efficacy and the HPV Genotype Profile of Genital Warts after Cryotherapy Failure and Podophyllotoxin Therapy in Male Patients.

ALA-PDT DNA HPV genital warts real-time PCR treatment efficacy

Journal

Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444

Informations de publication

Date de publication:
14 Feb 2021
Historique:
received: 04 01 2021
revised: 01 02 2021
accepted: 10 02 2021
entrez: 6 3 2021
pubmed: 7 3 2021
medline: 7 3 2021
Statut: epublish

Résumé

Genital warts are the manifestation of the human papillomavirus (HPV) infection, which may last for weeks or months before the clinical presentation. The primary aim of the study was the correlation of the DNA HPV genotypes eradication with the treatment response in male patients with persistent genital warts. Twenty-one male patients (age range: 22-58) after failure of cryotherapy and podophyllotoxin treatment were enrolled in the study. Genetic tests (Real Time - PCR method) analyzed the presence of DNA-HPV before and 6 months after four sessions (4 weeks apart) of photodynamic therapy with 5-aminolaevulinic acid (ALA-PDT). The treatment efficacy was evaluated before each PDT session and at the end of the study. The single HPV DNA type was present in 15/21 of the patients (13/15 HPV6). The high-risk HPV types were found in 8/21 subjects, of which 6/8 had several types. Six months after four sessions of PDT, complete response was found in 16/21 (76.19%; ALA-PDT is an effective treatment even after the failure of previous modalities. The persistence of clinical lesions and high oncological risk HPV types should be an indication for treatment prolongation.

Sections du résumé

BACKGROUND BACKGROUND
Genital warts are the manifestation of the human papillomavirus (HPV) infection, which may last for weeks or months before the clinical presentation. The primary aim of the study was the correlation of the DNA HPV genotypes eradication with the treatment response in male patients with persistent genital warts.
METHODS METHODS
Twenty-one male patients (age range: 22-58) after failure of cryotherapy and podophyllotoxin treatment were enrolled in the study. Genetic tests (Real Time - PCR method) analyzed the presence of DNA-HPV before and 6 months after four sessions (4 weeks apart) of photodynamic therapy with 5-aminolaevulinic acid (ALA-PDT). The treatment efficacy was evaluated before each PDT session and at the end of the study.
RESULTS RESULTS
The single HPV DNA type was present in 15/21 of the patients (13/15 HPV6). The high-risk HPV types were found in 8/21 subjects, of which 6/8 had several types. Six months after four sessions of PDT, complete response was found in 16/21 (76.19%;
CONCLUSION CONCLUSIONS
ALA-PDT is an effective treatment even after the failure of previous modalities. The persistence of clinical lesions and high oncological risk HPV types should be an indication for treatment prolongation.

Identifiants

pubmed: 33672889
pii: life11020146
doi: 10.3390/life11020146
pmc: PMC7918501
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Pak J Med Sci. 2016 Jul-Aug;32(4):961-4
pubmed: 27648048
Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2036-43
pubmed: 18708396
J Clin Aesthet Dermatol. 2012 Jun;5(6):25-36
pubmed: 22768354
J Infect Dis. 2006 Oct 15;194(8):1044-57
pubmed: 16991079
Int J Cancer. 2017 Jul 1;141(1):8-23
pubmed: 28124442
J Dtsch Dermatol Ges. 2016 Sep;14(9):892-9
pubmed: 27607030
Photodiagnosis Photodyn Ther. 2018 Sep;23:362-364
pubmed: 30048762
BMC Infect Dis. 2019 May 2;19(1):375
pubmed: 31046696
Heliyon. 2020 Mar 11;6(3):e03547
pubmed: 32190761
Can Fam Physician. 2013 Jul;59(7):731-6
pubmed: 23851535
Lancet. 2011 Mar 12;377(9769):932-40
pubmed: 21367446
Photodiagnosis Photodyn Ther. 2019 Dec;28:114-119
pubmed: 31479803
Int J Clin Exp Med. 2015 Jul 15;8(7):11342-6
pubmed: 26379947
Photodiagnosis Photodyn Ther. 2018 Mar;21:86-90
pubmed: 29155073
Drugs Context. 2018 Dec 19;7:212563
pubmed: 30622585
Phytochemistry. 2000 May;54(2):115-20
pubmed: 10872202
J Eur Acad Dermatol Venereol. 2019 Jun;33(6):1006-1019
pubmed: 30968980
J Infect Dis. 2012 May 15;205(10):1544-53
pubmed: 22427679
BMC Public Health. 2020 Sep 25;20(1):1455
pubmed: 32977797
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):1644-1653
pubmed: 32735077
Photodiagnosis Photodyn Ther. 2017 Sep;19:140-152
pubmed: 28647616
J Infect Dis. 2009 Feb 1;199(3):362-71
pubmed: 19133808
J Cell Biochem. 2019 Aug;120(8):12870-12874
pubmed: 30868650
Curr Opin Virol. 2013 Aug;3(4):416-21
pubmed: 23816390
Virol J. 2013 May 01;10:137
pubmed: 23634957
Int J Clin Exp Med. 2015 Apr 15;8(4):6517-21
pubmed: 26131281

Auteurs

Witold Owczarek (W)

Department of Dermatology, Military Institute of Medicine, 01-755 Warsaw, Poland.

Monika Slowinska (M)

Department of Dermatology, Military Institute of Medicine, 01-755 Warsaw, Poland.

Irena Walecka (I)

Clinic of Dermatology, Centre of Postgraduate Medical Education, Central Clinical Hospital of the Ministry of the Interior, 02-097 Warsaw, Poland.

Magdalena Ciazynska (M)

Department of Proliferative Diseases, Nicolaus Copernicus Multidisciplinary Centre for Oncology and Traumatology, 87-100 Torun, Poland.

Dorota Nowicka (D)

Department of Dermatology and Venereology, Medical University of Warsaw, 02-091 Warsaw, Poland.

Leszek Walczak (L)

Department of Dermatology, Military Institute of Medicine, 01-755 Warsaw, Poland.

Elwira Paluchowska (E)

Department of Dermatology, Military Institute of Medicine, 01-755 Warsaw, Poland.

Classifications MeSH